Switch to:
More From Other Websites
Where Do Dividend Opportunities Lie Today? May 21 2015
Innovators to Support Healthcare Sector, ETFs’ Growth May 20 2015
Blue Ridge Capital Reduces Position in Actavis May 12 2015
Mylan’s Share Price Declines 3% on 1Q15 Earnings May 12 2015
Mylan’s Pursuit of Perrigo Could Yield Massive Synergies May 11 2015
The Many Reasons Mylan Is So Keen to Acquire Perrigo May 11 2015
What Investors Can Expect from Pfizer in 2015 May 11 2015
Teva’s Shares Dip over 1Q15 Earnings May 11 2015
Key Factors That Impact Johnson & Johnson’s Forward Valuation May 11 2015
Pfizer Stock Dips over 1Q15 Forward Valuation Concerns May 09 2015
Why Teva’s Generic Medicines Profitability Improved in 1Q15 May 08 2015
Why Teva’s Specialty Medicines Performance Declined in 1Q15 May 08 2015
Where Mylan Saw 1Q15 Revenue Increase May 08 2015
Mylan Reports 1Q15 Earnings Per Share Growth of 6% May 08 2015
Pfizer Revenues Hit by Lost Exclusivity in 1Q15 May 08 2015
Pfizer’s Exposure to Overseas Markets Soaks 1Q15 Revenues May 08 2015
Why Teva’s 1Q15 Revenues Declined Marginally May 06 2015
Teva’s Adjusted Earnings Per Share Improved 11% in 1Q15 May 06 2015
Shares Rise 2% after Novartis Posts 1Q15 Earnings May 06 2015
Is Novartis an Up-and-Coming Oncology Powerhouse? May 05 2015

No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership